ZimVie (ZIMV) Stock Forecast, Price Target & Predictions
ZIMV Stock Forecast
ZimVie stock forecast is as follows: an average price target of $14.50 (represents a 0.49% upside from ZIMV’s last price of $14.43) and a rating consensus of 'Buy', based on 2 wall street analysts offering a 1-year stock forecast.
ZIMV Price Target
The average price target for ZimVie (ZIMV) is $14.50 based on 1-year price targets from 2 Wall Street analysts in the past 3 months, with a price target range of $20.00 to $9.00. This represents a potential 0.49% upside from ZIMV's last price of $14.43.
ZIMV Analyst Ratings
According to 2 Wall Street analysts, ZimVie's rating consensus is 'Buy'. The analyst rating breakdown for ZIMV stock is 0 'Strong Buy' (0.00%), 1 'Buy' (50.00%), 0 'Hold' (0.00%), 1 'Sell' (50.00%), and 0 'Strong Sell' (0.00%).
ZimVie Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| May 16, 2024 | David Saxon | Needham | $20.00 | $16.68 | 19.90% | 38.60% |
| Dec 21, 2022 | - | Barclays | $9.00 | $8.70 | 3.45% | -37.63% |
The latest ZimVie stock forecast, released on May 16, 2024 by David Saxon from Needham, set a price target of $20.00, which represents a 19.90% increase from the stock price at the time of the forecast ($16.68), and a 38.60% increase from ZIMV last price ($14.43).
ZimVie Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | - | 1 |
| Avg Price Target | - | - | $20.00 |
| Last Closing Price | $14.43 | $14.43 | $14.43 |
| Upside/Downside | -100.00% | -100.00% | 38.60% |
In the current month, the average price target of ZimVie stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to ZimVie's last price of $14.43. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Jun 25, 2024 | Needham | Buy | Buy | Hold |
| May 16, 2024 | Needham | - | Buy | Upgrade |
| Aug 08, 2023 | Barclays | Underweight | Underweight | Hold |
| Dec 21, 2022 | Barclays | - | Underweight | Initialise |
ZimVie's last stock rating was published by Needham on Jun 25, 2024. The company gave ZIMV a "Buy" rating, the same as its previous rate.
ZimVie Financial Forecast
ZimVie Revenue Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | $202.87M | $224.90M | $225.43M | $229.12M | $214.58M | $234.56M | $235.60M | $261.60M |
| Avg Forecast | $114.51M | $104.58M | $118.45M | $119.38M | $113.40M | $103.22M | $115.00M | $116.00M | $213.00M | $196.00M | $212.00M | $207.00M | $237.00M | $215.00M | $233.37M | $224.87M | $260.70M |
| High Forecast | $114.51M | $104.58M | $118.45M | $119.38M | $113.40M | $104.13M | $115.00M | $116.00M | $213.00M | $196.00M | $212.00M | $207.00M | $237.00M | $215.00M | $233.37M | $224.87M | $260.70M |
| Low Forecast | $114.51M | $104.58M | $118.45M | $119.38M | $113.40M | $102.31M | $115.00M | $116.00M | $213.00M | $196.00M | $212.00M | $207.00M | $237.00M | $215.00M | $233.37M | $224.87M | $260.70M |
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Surprise % | - | - | - | - | - | - | - | - | - | 1.04% | 1.06% | 1.09% | 0.97% | 1.00% | 1.01% | 1.05% | 1.00% |
ZimVie's average Quarter revenue forecast for Dec 23 based on 1 analysts is $213.00M, with a low forecast of $213.00M, and a high forecast of $213.00M. ZIMV's average Quarter revenue forecast represents a 4.99% increase compared to the company's last Quarter revenue of $202.87M (Sep 23).
ZimVie EBITDA Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| EBITDA | - | - | - | - | - | - | - | - | - | $57.88M | $61.37M | $22.26M | $7.75M | $22.56M | $22.06M | $9.93M | $-18.30M |
| Avg Forecast | $12.73M | $11.62M | $13.16M | $13.27M | $12.60M | $11.47M | $12.78M | $12.89M | $23.67M | $21.78M | $23.56M | $23.00M | $26.34M | $23.89M | $25.93M | $24.99M | $28.97M |
| High Forecast | $12.73M | $11.62M | $13.16M | $13.27M | $12.60M | $11.57M | $12.78M | $12.89M | $23.67M | $21.78M | $23.56M | $23.00M | $26.34M | $23.89M | $25.93M | $24.99M | $28.97M |
| Low Forecast | $12.73M | $11.62M | $13.16M | $13.27M | $12.60M | $11.37M | $12.78M | $12.89M | $23.67M | $21.78M | $23.56M | $23.00M | $26.34M | $23.89M | $25.93M | $24.99M | $28.97M |
| Surprise % | - | - | - | - | - | - | - | - | - | 2.66% | 2.60% | 0.97% | 0.29% | 0.94% | 0.85% | 0.40% | -0.63% |
1 analysts predict ZIMV's average Quarter EBITDA for Dec 23 to be $23.67M, with a high of $23.67M and a low of $23.67M. This is -59.10% lower than ZimVie's previous annual EBITDA (Sep 23) of $57.88M.
ZimVie Net Income Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Net Income | - | - | - | - | - | - | - | - | - | $-5.09M | $-23.37M | $-29.97M | $-30.34M | $831.00K | $-8.71M | $-25.66M | $-60.70M |
| Avg Forecast | $6.03M | $3.29M | $4.93M | $3.84M | $6.85M | $3.27M | $4.80M | $-1.10M | $3.43M | $-548.10K | $685.13K | $1.51M | $5.76M | $7.40M | $18.49M | $10.34M | $21.92M |
| High Forecast | $6.03M | $3.29M | $4.93M | $3.84M | $6.85M | $3.27M | $4.80M | $-1.10M | $3.43M | $-548.10K | $685.13K | $1.51M | $5.76M | $7.40M | $18.49M | $10.34M | $21.92M |
| Low Forecast | $6.03M | $3.29M | $4.93M | $3.84M | $6.85M | $3.27M | $4.80M | $-1.10M | $3.43M | $-548.10K | $685.13K | $1.51M | $5.76M | $7.40M | $18.49M | $10.34M | $21.92M |
| Surprise % | - | - | - | - | - | - | - | - | - | 9.28% | -34.11% | -19.88% | -5.27% | 0.11% | -0.47% | -2.48% | -2.77% |
ZimVie's average Quarter net income forecast for Dec 22 is $5.76M, with a range of $5.76M to $5.76M. ZIMV's average Quarter net income forecast represents a 592.55% increase compared to the company's last Quarter net income of $831.00K (Sep 22).
ZimVie SG&A Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| SG&A | - | - | - | - | - | - | - | - | - | $117.35M | $128.48M | $127.97M | $134.46M | $129.34M | $126.05M | $134.11M | $149.30M |
| Avg Forecast | $64.64M | $59.03M | $66.86M | $67.38M | $64.01M | $58.27M | $64.91M | $65.48M | $120.23M | $110.64M | $119.67M | $116.84M | $133.78M | $121.36M | $131.73M | $126.93M | $147.16M |
| High Forecast | $64.64M | $59.03M | $66.86M | $67.38M | $64.01M | $58.78M | $64.91M | $65.48M | $120.23M | $110.64M | $119.67M | $116.84M | $133.78M | $121.36M | $131.73M | $126.93M | $147.16M |
| Low Forecast | $64.64M | $59.03M | $66.86M | $67.38M | $64.01M | $57.75M | $64.91M | $65.48M | $120.23M | $110.64M | $119.67M | $116.84M | $133.78M | $121.36M | $131.73M | $126.93M | $147.16M |
| Surprise % | - | - | - | - | - | - | - | - | - | 1.06% | 1.07% | 1.10% | 1.01% | 1.07% | 0.96% | 1.06% | 1.01% |
ZimVie's average Quarter SG&A projection for Dec 23 is $120.23M, based on 1 Wall Street analysts, with a range of $120.23M to $120.23M. The forecast indicates a 2.45% rise compared to ZIMV last annual SG&A of $117.35M (Sep 23).
ZimVie EPS Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| EPS | - | - | - | - | - | - | - | - | - | $-0.19 | $-0.89 | $-1.14 | $-1.16 | $0.03 | $-0.33 | $-0.98 | $-2.33 |
| Avg Forecast | $0.22 | $0.12 | $0.18 | $0.14 | $0.25 | $0.12 | $0.17 | $-0.04 | $0.13 | $-0.02 | $0.03 | $0.06 | $0.21 | $0.27 | $0.67 | $0.38 | $0.80 |
| High Forecast | $0.22 | $0.12 | $0.18 | $0.14 | $0.25 | $0.12 | $0.17 | $-0.04 | $0.13 | $-0.02 | $0.03 | $0.06 | $0.21 | $0.27 | $0.67 | $0.38 | $0.80 |
| Low Forecast | $0.22 | $0.12 | $0.18 | $0.14 | $0.25 | $0.12 | $0.17 | $-0.04 | $0.13 | $-0.02 | $0.03 | $0.06 | $0.21 | $0.27 | $0.67 | $0.38 | $0.80 |
| Surprise % | - | - | - | - | - | - | - | - | - | 9.50% | -35.60% | -20.73% | -5.52% | 0.11% | -0.49% | -2.60% | -2.91% |
According to 1 Wall Street analysts, ZimVie's projected average Quarter EPS for Dec 22 is $0.21, with a low estimate of $0.21 and a high estimate of $0.21. This represents a 600.00% increase compared to ZIMV previous annual EPS of $0.03 (Sep 22).
ZimVie Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| APYX | Apyx Medical | $1.16 | $8.50 | 632.76% | Buy |
| INGN | Inogen | $9.03 | $26.00 | 187.93% | Buy |
| SGHT | Sight Sciences | $4.66 | $10.25 | 119.96% | Hold |
| NPCE | NeuroPace | $6.37 | $12.88 | 102.20% | Buy |
| OFIX | Orthofix Medical | $17.33 | $31.00 | 78.88% | - |
| LUNG | Pulmonx | $7.12 | $11.93 | 67.56% | Buy |
| SIBN | SI-BONE | $13.63 | $20.00 | 46.74% | Buy |
| KIDS | OrthoPediatrics | $28.74 | $39.60 | 37.79% | Buy |
| CNMD | CONMED | $70.47 | $96.00 | 36.23% | Buy |
| STE | STERIS | $225.82 | $256.67 | 13.66% | Buy |
| AORT | Artivion | $27.46 | $30.60 | 11.43% | Buy |
| CVRX | CVRx | $15.05 | $16.33 | 8.50% | Buy |
| SRDX | Surmodics | $37.57 | $39.50 | 5.14% | Buy |
| ZIMV | ZimVie | $14.43 | $14.50 | 0.49% | Buy |
| SYK | Stryker | $366.90 | $317.96 | -13.34% | Buy |
ZIMV Forecast FAQ
Is ZimVie a good buy?
Yes, according to 2 Wall Street analysts, ZimVie (ZIMV) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 1 'Buy' recommendations, accounting for 50.00% of ZIMV's total ratings.
What is ZIMV's price target?
ZimVie (ZIMV) average price target is $14.5 with a range of $9 to $20, implying a 0.49% from its last price of $14.43. The data is based on 2 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will ZimVie stock go up soon?
According to Wall Street analysts' prediction for ZIMV stock, the company can go up by 0.49% (from the last price of $14.43 to the average price target of $14.5), up by 38.60% based on the highest stock price target, and down by -37.63% based on the lowest stock price target.
Can ZimVie stock reach $20?
ZIMV's average twelve months analyst stock price target of $14.5 does not support the claim that ZimVie can reach $20 in the near future.
What are ZimVie's analysts' financial forecasts?
ZimVie's analysts financial forecasts for the fiscal year (Dec 2024) are as follows: average revenue is $447.62M (high $448.53M, low $446.71M), average EBITDA is $49.75M (high $49.85M, low $49.64M), average net income is $13.82M (high $13.82M, low $13.82M), average SG&A $252.67M (high $253.18M, low $252.15M), and average EPS is $0.504 (high $0.504, low $0.504). ZIMV's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $456.92M (high $456.92M, low $456.92M), average EBITDA is $50.78M (high $50.78M, low $50.78M), average net income is $18.09M (high $18.09M, low $18.09M), average SG&A $257.92M (high $257.92M, low $257.92M), and average EPS is $0.66 (high $0.66, low $0.66).
Did the ZIMV's actual financial results beat the analysts' financial forecasts?
Based on ZimVie's last annual report (Dec 2022), the company's revenue was $913.86M, beating the average analysts forecast of $910.23M by 0.40%. Apple's EBITDA was $71.94M, missing the average prediction of $101.16M by -28.88%. The company's net income was $-63.881M, missing the average estimation of $41.98M by -252.16%. Apple's SG&A was $523.97M, beating the average forecast of $513.8M by 1.98%. Lastly, the company's EPS was $-2.45, missing the average prediction of $1.53 by -259.92%. In terms of the last quarterly report (Sep 2023), ZimVie's revenue was $202.87M, beating the average analysts' forecast of $196M by 3.51%. The company's EBITDA was $57.88M, beating the average prediction of $21.78M by 165.73%. ZimVie's net income was $-5.089M, beating the average estimation of $-548K by 828.48%. The company's SG&A was $117.35M, beating the average forecast of $110.64M by 6.07%. Lastly, the company's EPS was $-0.19, beating the average prediction of $-0.02 by 850.00%